Literature DB >> 34727063

Metabolic alkalosis following mitral valvuloplasty in a dog with preoperative acute kidney injury.

Katsuhiro Matsuura, Tomohiko Yoshida, Takuya Uehara, Shusaku Yamada, Hideki Yotsuida, Mizuki Hasegawa, Sakie Katayose, Kurumi Yamada, Youta Yaginuma.   

Abstract

CASE DESCRIPTION: An 11-year-old sexually intact male Shih Tzu diagnosed with acute kidney injury and left-sided congestive heart failure that had nonelective mitral valve surgery. CLINICAL
FINDINGS: Metabolic alkalosis developed postoperatively, and plasma bicarbonate concentration peaked 2 days after surgery (40.2 mmol/L; pH, 7.550). TREATMENT AND OUTCOME: Acetazolamide administration increased the urinary excretion of bicarbonate and contributed to the improvement of the dog's acid-base status and oxygenation capacity. Metabolic alkalosis persisted for 4 days after surgery, and no treatment was required after resolution. Plasma urea nitrogen and creatinine concentrations normalized 2 days after surgery. CLINICAL RELEVANCE: Severe metabolic alkalosis can occur as a complication following mitral valve surgery. Acetazolamide may be suitable for the treatment of severe metabolic alkalosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34727063     DOI: 10.2460/javma.20.09.0519

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.

Authors:  Chieh-Jen Cheng; Ahmed S Mandour; Tomohiko Yoshida; Toshihiro Watari; Ryou Tanaka; Katsuhiro Matsuura
Journal:  J Vet Intern Med       Date:  2022-01-07       Impact factor: 3.333

2.  Mitral valvuloplasty with left atrial appendage closure and pacemaker implantation in a dog with severe myxomatous mitral valve degeneration: a case report.

Authors:  Tomohiko Yoshida; Ryosuke Namiki; Katsuhiro Matsuura
Journal:  BMC Vet Res       Date:  2022-05-16       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.